Clinical Trial Update: Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating romiplostim for thrombocytopenia in hepatitis C-infected patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Thrombocytopenia

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: University of Southern California | Conditions: Hepatitis C Infection, Thrombocytopenia | Phase 2 | Status: TERMINATED